Detergent and antigen fragility affect the ELISA for measurement of anti-prothrombin autoantibodies

Journal of Rheumatology

Volumn 26, Issue 3, 1999, Pages 580-587

  Akimoto, Takayuki ^c   Akama, Takao ^a,b   Kono, Ichiro ^a   Yamane, Kazuhide ^a   Sumida, Takayuki ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

^c NONE

Author keywords

Antiphospholipid antibodies; Antiphospholipid syndrome; ELISA; Prothrombin; Systemic lupus erythematosus

Indexed keywords

ANTIGEN; AUTOANTIBODY; BUFFER; DETERGENT; LUPUS ANTICOAGULANT; PHOSPHATE; POLYSORBATE 20; POLYSTYRENE; PROTHROMBIN; SODIUM CHLORIDE; TROMETAMOL;

ANTIBODY DETECTION; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GAMMA IRRADIATION; HUMAN; HUMAN TISSUE; LUPUS ERYTHEMATOSUS; MALE; PRIORITY JOURNAL;

ANTIPHOSPHOLIPID SYNDROME; AUTOANTIBODIES; AUTOANTIGENS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; POLYSORBATES; PROTHROMBIN; SURFACE-ACTIVE AGENTS;

EID: 0033021198     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Bajaj SP, Rapaport SI, Fierer DS, Herbst KD, Schwartz DB. A mechanism for the hypoprothrombinemia of the acquired hypoprothrombinemia-lupus anticoagulant syndrome. Blood 1983;61:684-92.
2. Bevers EM, Galli M, Barbui T, Comfurius P, Zwaal RF. Lupus anticoagulant IgG are not directed to phospholipids only, but to a complex of lipid-bound human prothrombin. Thromb Haemost 1991;66:629-32.
3. Rao LVM, Hoang AD, Rapaport S. Mechanism and effects of the binding of lupus anticoagulant IgG and prothrombin to surface phospholipid. Blood 1996;88:4173-82.
4. Matsuda J, Saitoh N, Gotoh M, Kawasugi K, Gohchi K, Tsukamoto M. Phosphatidyl serine-dependent antiprothrombin antibody is exclusive to patients with lupus anticoagulant. Br J Rheumatol 1996;35:589-91.
5. 2-glycoprotein I in the expression of lupus anticoagulant activity. Blood 1994;83:2878-92.
6. Matsuda J, Saitoh N, Tsukamoto M, Gotoh M, Gohchi K, Kawasugi K. Buffer may be the critical factor in measurement of anti-prothrombin antibody on a gamma-ray-irradiated plate by enzyme-linked immunosorbent assay. Am J Hematol 1996;53:242-4.
7. Arvieux J, Darnige L, Caron C, Reber G, Bensa JC, Colomb MG. Development of an ELlSA for autoantibodies to prothrombin showing their prevalence in patients with lupus anticoagulants. Thromb Haemost 1995;74:1120-5.
8. Tan EM, Cohen AS, Fries JF. The 1982 revised criteria for the classification of SLE. Arthritis Rheum 1982;25:1271-7.
9. Harris EN. Syndrome of the black swan. Br J Rheumatol 1987;26:324-6.
10. Matsuura E, Igarashi Y, Fujimoto M, et al. Heterogeneity of anticardiolipin antibodies defined by the anticardiolipin cofactor. J Immunol 1992;148:3885-91.
11. Triplett DA, Barna LK, Unger GA. A hexagonal (II) phase phospholipid neutralization assay for lupus anticoagulant identification. Thromb Haemost 1993;70:787-93.
12. Roisin JP, Migaud M, Morel S, Martinoli JL. Diagnosis of lupus anticoagulants using three new standarized reagents [abstract]. 5th International Symposium on Antiphospholipid Antibodies 1992: Suppl:3.
13. Arnout J, Vanrusselt M, Huybrechts E, Vermylen J. Optimization of the dilute prothrombin time for detection of the lupus anticoagulant by use of a recombinant tissue thromboplastin. Br J Haematol 1994;87:94-9.
14. Ahmad SS, Rawala-Sheikh R, Thompson AR, Walsh PN. Rapid purification of factor IX, factor X and prothrombin by immunoaffinity and ion exchange chromatography. Thromb Res 1989;55:121-33.
15. Miletich JP, Braze GJ, Majerus PW. The synthesis of sulfated dextran beads for isolation of human plasma coagulation factor II, IX, and X. Anal Biochem 1980;105:304-10.
16. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-5.
17. Mann KG. Prothrombin. Methods Enzymol 1976;45:123-55.
18. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-54.
19. Onyiriuka EC, Hersh IS, Herti W. Surface modification of polystyrene by gamma-radiation. Appl Spectr 1990;44:808-15.
20. 2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface. J Exp Med 1994;179:457-62.
21. 2-glycoprotein I in the absence of phospholipid. J Immunol 1995;154:954-60.
22. Ravindranath MH, Ravindranath RMH, Motion DL, Graves MC. Factors affecting the fine specificity and sensitivity of serum antiganglioside antibodies in ELISA. J Immunol Methods 1994;169:257-72.
23. Engvall E, Perlmann PH. Enzyme-linked immunosorbent assay. ELISA. J Immunol Methods 1972;109:129-33.
24. Ming CH, Fan YS. Enhancement of anti-phospholipid antibody activity by Tween-20. J Immunol Methods 1988;109:253-5.
25. 2,-glycoprotein I as an antigen. J Immunol Methods 1991;143:223-9.
26. 2-glycoprotein I dependent (systemic lupus erythematosus type) and independent (syphilis type) anticardiolipin antibody with Tween 20. Br J Haematol 1993;85:799-802.
27. Stevens PW, Hansberry MR, Kelso DM. Assesment of adsorption and adhesion of microwells sequential enzyme-linked immunosorbent assay analysis. Anal Biochem 1995;225:197-205.
28. Rao LVM, Hoang AD, Rapaport S. Differences in the interactions of lupus anticoagulant IgG with human prothrombin and bovine prothrombin. Thromb Haemost 1995;73:668-74.
29. Cote HCF, Huntsman DG, Wu J, Wadsworth LD, MacGillivray RT. A new method for characterization and epitope determination of a lupus anticoagulant-associated neutralizing antiprothrombin antibody. Am J Pathol 1997;107:196-204.
30. Salcido F, Cabiedes J, Alarcon-Segovia D, Cabrai AR. Anti-prothrombin antibodies in patients with systemic lupus erythematosus or with primary antiphospholipid syndrome [abstract]. Lupus 1997;7 Suppl 1:42.
31. Balestrieri G. Tincani A, Spatola L, et al. Are autoantibodies to native prothrombin related to antiphospholipid syndrome? [abstract]. Lupus 1997;7 Suppl 1:44.
32. Emlen W. Antiphospholipid antibodies: New complexities and new assays [editorial]. Arthritis Rheum 1996;39:1441-3.